SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-013181
Filing Date
2022-08-11
Accepted
2022-08-11 07:31:31
Documents
98
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q ipsc-20220630x10q.htm   iXBRL 10-Q 2166114
2 EX-10.1 ipsc-20220630xex10d1.htm EX-10.1 61453
3 EX-31.1 ipsc-20220630xex31d1.htm EX-31.1 11878
4 EX-31.2 ipsc-20220630xex31d2.htm EX-31.2 11720
5 EX-32.1 ipsc-20220630xex32d1.htm EX-32.1 6204
6 EX-32.2 ipsc-20220630xex32d2.htm EX-32.2 6198
7 GRAPHIC ipsc-20220630xex10d1002.jpg GRAPHIC 2759
8 GRAPHIC ipsc-20220630xex10d1001.jpg GRAPHIC 2952
  Complete submission text file 0001558370-22-013181.txt   9220048

Data Files

Seq Description Document Type Size
9 EX-101.SCH ipsc-20220630.xsd EX-101.SCH 67459
10 EX-101.CAL ipsc-20220630_cal.xml EX-101.CAL 74286
11 EX-101.DEF ipsc-20220630_def.xml EX-101.DEF 268745
12 EX-101.LAB ipsc-20220630_lab.xml EX-101.LAB 577957
13 EX-101.PRE ipsc-20220630_pre.xml EX-101.PRE 458413
92 EXTRACTED XBRL INSTANCE DOCUMENT ipsc-20220630x10q_htm.xml XML 1537590
Mailing Address 3675 MARKET STREET PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

IRS No.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40498 | Film No.: 221153702
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences